BioWorld

Oct. 5, 2009

View Archived Issues

AIDSVax Results Likely Not Enough to Rescue VaxGen

Orexigen's New Empatic Data: Nice Obesity-Partner Package

Money Raised By Biotech in 2009: Jan 1 – Oct 1, 2009

Week in Review

Word on the Street

Public Financing Of Biotechnology: September 2009

BioTech Money Raised By Month in 2009: January – September

Other Financings Of Public Biotechnology Companies: September 2009

Venture Capital And Other Investments In Private Biotechnology Companies: September 2009

Milestone Payments From Corporate Partners: September 2009

Stock Indexes

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Recent Data May Resurrect Both AIDSVax and HIV Field

News that an HIV vaccine actually worked could resurrect AIDSVax, a product most folks left for dead in 2003, while breathing new life into the HIV vaccine field. Read More

Money Raised Year to Date

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...

Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

BioWorld Science

Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...